Intrinsic Value of S&P & Nasdaq Contact Us

Kronos Bio, Inc. KRON

NASDAQ Global Select

SharesGrow Score
64/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.63
+85.2%

Kronos Bio, Inc. (KRON) current share price is $0.88. The gold spot price is $4,825.20 per troy ounce. Using the formula: KRON in gold = $0.88 × 31.1035 ÷ $4,825.20 = 0.0057 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of KRON when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding KRON shares over the measured period.

KRON in US Dollars
Gold in US Dollars
KRON in Gold (grams per share)

Real Wealth Growth Rate

KRON
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{KRON}_{\text{gold}}(t) = \frac{P_{\text{KRON}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{KRON}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{KRON}_{\text{gold}}^{(T)}}{\text{KRON}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{KRON}_\text{gold}^{(0)}$ = initial gold-price, $\text{KRON}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

MRUS
MRUS
Merus N.V.
$90.00
+0.00%
ERAS
ERAS
Erasca, Inc.
$17.85
+9.44%
CRNX
CRNX
Crinetics Pharmaceuticals, Inc.
$39.75
+2.82%
EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
INBX
INBX
Inhibrx Biosciences, Inc.
$83.19
+7.40%
CTMX
CTMX
CytomX Therapeutics, Inc.
$4.54
+3.42%
LYEL
LYEL
Lyell Immunopharma, Inc.
$23.37
-5.77%
ASMB
ASMB
Assembly Biosciences, Inc.
$29.44
+0.68%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message